Creative Planning’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $48.9M | Buy |
109,524
+9,011
| +9% | +$4.2M | 0.03% | 223 |
|
|
2025
Q4 | $45.6M | Buy |
100,513
+5,649
| +6% | +$2.43M | 0.03% | 217 |
|
|
2025
Q3 | $37.2M | Buy |
94,864
+7,690
| +9% | +$3.21M | 0.03% | 242 |
|
|
2025
Q2 | $38.8M | Sell |
87,174
-1,666
| -2% | -$768K | 0.03% | 214 |
|
|
2025
Q1 | $43.1M | Buy |
88,840
+9,370
| +12% | +$4.37M | 0.04% | 190 |
|
|
2024
Q4 | $32M | Sell |
79,470
-997
| -1% | -$462K | 0.03% | 209 |
|
|
2024
Q3 | $37.4M | Buy |
80,467
+1,350
| +2% | +$648K | 0.04% | 183 |
|
|
2024
Q2 | $37.1M | Buy |
79,117
+3,998
| +5% | +$1.74M | 0.04% | 174 |
|
|
2024
Q1 | $31.4M | Buy |
75,119
+1,883
| +3% | +$796K | 0.03% | 189 |
|
|
2023
Q4 | $29.8M | Sell |
73,236
-48,292
| -40% | -$17.8M | 0.06% | 187 |
|
|
2023
Q3 | $42.3M | Buy |
121,528
+52,243
| +75% | +$18.3M | 0.06% | 140 |
|
|
2023
Q2 | $24.4M | Buy |
69,285
+2,589
| +4% | +$872K | 0.03% | 193 |
|
|
2023
Q1 | $21M | Buy |
66,696
+1,236
| +2% | +$371K | 0.03% | 208 |
|
|
2022
Q4 | $18.9M | Buy |
65,460
+56,673
| +645% | +$17.3M | 0.03% | 226 |
|
|
2022
Q3 | $2.54M | Sell |
8,787
-4,318
| -33% | -$1.24M | ﹤0.01% | 615 |
|
|
2022
Q2 | $3.69M | Buy |
13,105
+7,280
| +125% | +$1.95M | 0.01% | 539 |
|
|
2022
Q1 | $1.52M | Sell |
5,825
-683
| -10% | -$162K | ﹤0.01% | 811 |
|
|
2021
Q4 | $1.43M | Sell |
6,508
-32,516
| -83% | -$6.32M | ﹤0.01% | 798 |
|
|
2021
Q3 | $7.08M | Buy |
39,024
+6,914
| +22% | +$1.35M | 0.01% | 333 |
|
|
2021
Q2 | $6.47M | Buy |
32,110
+25,348
| +375% | +$5.3M | 0.01% | 345 |
|
|
2021
Q1 | $1.45M | Buy |
6,762
+359
| +6% | +$78.9K | ﹤0.01% | 851 |
|
|
2020
Q4 | $1.51M | Sell |
6,403
-29
| -0.5% | -$6.65K | ﹤0.01% | 775 |
|
|
2020
Q3 | $1.75M | Buy |
6,432
+2,468
| +62% | +$681K | ﹤0.01% | 612 |
|
|
2020
Q2 | $1.15M | Buy |
3,964
+1,013
| +34% | +$275K | ﹤0.01% | 695 |
|
|
2020
Q1 | $702K | Sell |
2,951
-564
| -16% | -$129K | ﹤0.01% | 789 |
|
|
2019
Q4 | $769K | Buy |
3,515
+134
| +4% | +$27.1K | ﹤0.01% | 907 |
|
|
2019
Q3 | $573K | Sell |
3,381
-187
| -5% | -$33.1K | ﹤0.01% | 991 |
|
|
2019
Q2 | $654K | Sell |
3,568
-423
| -11% | -$73.9K | ﹤0.01% | 937 |
|
|
2019
Q1 | $734K | Sell |
3,991
-261
| -6% | -$48.2K | ﹤0.01% | 857 |
|
|
2018
Q4 | $705K | Buy |
4,252
+253
| +6% | +$43.8K | ﹤0.01% | 808 |
|
|
2018
Q3 | $771K | Buy |
3,999
+491
| +14% | +$87.4K | ﹤0.01% | 867 |
|
|
2018
Q2 | $596K | Sell |
3,508
-132
| -4% | -$20.5K | ﹤0.01% | 978 |
|
|
2018
Q1 | $593K | Sell |
3,640
-723
| -17% | -$118K | ﹤0.01% | 998 |
|
|
2017
Q4 | $654K | Buy |
4,363
+513
| +13% | +$76K | ﹤0.01% | 923 |
|
|
2017
Q3 | $585K | Buy |
3,850
+134
| +4% | +$20.2K | ﹤0.01% | 973 |
|
|
2017
Q2 | $479K | Buy |
3,716
+917
| +33% | +$110K | ﹤0.01% | 1033 |
|
|
2017
Q1 | $306K | Sell |
2,799
-2,265
| -45% | -$199K | ﹤0.01% | 1245 |
|
|
2016
Q4 | $373K | Sell |
5,064
-490
| -9% | -$39.9K | ﹤0.01% | 1077 |
|
|
2016
Q3 | $484K | Buy |
5,554
+305
| +6% | +$28.8K | ﹤0.01% | 914 |
|
|
2016
Q2 | $451K | Buy |
5,249
+102
| +2% | +$8.81K | ﹤0.01% | 828 |
|
|
2016
Q1 | $409K | Sell |
5,147
-189
| -4% | -$17.1K | ﹤0.01% | 832 |
|
|
2015
Q4 | $671K | Buy |
5,336
+1,945
| +57% | +$235K | 0.01% | 634 |
|
|
2015
Q3 | $353K | Buy |
+3,391
| New | +$436K | ﹤0.01% | 893 |
|
|
2015
Q2 | – | Sell |
-3,045
| Closed | -$359K | – | 2989 |
|
|
2015
Q1 | $359K | Sell |
3,045
-37
| -1% | -$4.43K | ﹤0.01% | 903 |
|
|
2014
Q4 | $366K | Buy |
3,082
+1,819
| +144% | +$205K | ﹤0.01% | 836 |
|
|
2014
Q3 | $142K | Sell |
1,263
-646
| -34% | -$61.5K | ﹤0.01% | 1255 |
|
|
2014
Q2 | $181K | Buy |
1,909
+547
| +40% | +$38.4K | ﹤0.01% | 1085 |
|
|
2014
Q1 | $96K | Buy |
1,362
+110
| +9% | +$8.71K | ﹤0.01% | 1426 |
|
|
2013
Q4 | $93K | Buy |
1,252
+8
| +0.6% | +$557 | ﹤0.01% | 1234 |
|
|
2013
Q3 | $94K | Buy |
1,244
+374
| +43% | +$29.8K | ﹤0.01% | 1153 |
|
|
2013
Q2 | $70K | Buy |
+870
| New | +$64.1K | ﹤0.01% | 1191 |
|
Other funds holding VRTX
VCM
VPM
Creative Planning's VRTX Position: Q1 2026 in Review
Creative Planning increased its Vertex Pharmaceuticals (VRTX) stake by 9% in Q1 2026, buying an estimated $4.2M and bringing the position to 109,524 shares worth $48.9M. The position accounts for 0.03% of the portfolio, ranked #223.
Creative Planning first reported a position in VRTX in Q2 2013 and has held it in 51 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Creative Planning held 109,524 shares of Vertex Pharmaceuticals worth $48.9M as of Q1 2026.
- Creative Planning bought 9,011 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.2M.
- Vertex Pharmaceuticals made up 0.03% of Creative Planning's portfolio in Q1 2026, its #223 holding.
- Creative Planning first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.